Imaging Diagnostic Systems, Inc.  

(Public, OTCMKTS:IMDS)   Watch this stock  
Find more results for imds
Sep 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.00
Open     -
Vol / Avg. 0.00/654,723.00
Mkt cap 503,180.00
P/E     -
Div/yield     -
EPS -0.19
Shares 2.12B
Beta -14.01
Inst. own 2%

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -25328.23% -1518.34%
Operating margin -27278.23% -1379.58%
EBITD margin - -1457.62%
Return on average assets -256.56% -448.86%
Return on average equity - -
Employees 10 -
CDP Score - -


1291b NW 65th Pl
United States - Map
+1-954-5819800 (Phone)
+1-954-9792420 (Fax)

Website links


Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a laser breast imaging system that uses computed tomography and laser techniques designed to detect breast abnormalities. As of June 30, 2012, IDSI was in the process of commercializing the computer tomography (CT) Laser Mammography system CTLM in certain international markets where approvals to market have been secured, although CTLM is not approved for sale in the United States. The CTLM system is a Diffuse Optical Tomography (DOT) CT-like scanner. Its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. CTLM is a new imaging modality offering the potential of functional molecular imaging, which can visualize the process of angiogenesis, which may be used to distinguish between benign and malignant tissue.